A detailed history of Gamma Investing LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Gamma Investing LLC holds 1,881 shares of RPRX stock, worth $48,341. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,881
Previous 1,625 15.75%
Holding current value
$48,341
Previous $42.9 Million 24.18%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$25.63 - $29.27 $6,561 - $7,493
256 Added 15.75%
1,881 $53.2 Million
Q2 2024

Jul 02, 2024

SELL
$26.26 - $29.9 $341 - $388
-13 Reduced 0.79%
1,625 $42.9 Million
Q1 2024

Apr 05, 2024

BUY
$27.46 - $31.33 $28,476 - $32,489
1,037 Added 172.55%
1,638 $49.7 Million
Q4 2023

Feb 01, 2024

BUY
$26.21 - $29.22 $15,752 - $17,561
601 New
601 $17.1 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.